Nepsis Inc. Gsk PLC Transaction History

Nepsis Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$42.05 - $47.77 $2,649 - $3,009	-63 Reduced 0.28%	22,519 $980,000
Q1 2022 Apr 13, 2022	BUY	$40.23 - $47.74 $908,473 - $1.08 Million	22,582 New	22,582 $984,000
Q4 2021 Jan 14, 2022	SELL	$38.88 - $45.31 $888,019 - $1.03 Million	-22,840 Closed	0 $0
Q3 2021 Oct 13, 2021	SELL	$38.79 - $43.16 $3,219 - $3,582	-83 Reduced 0.36%	22,840 $873,000
Q2 2021 Jul 15, 2021	BUY	$36.52 - $41.46 $1,132 - $1,285	31 Added 0.14%	22,923 $913,000
Q1 2021 Apr 20, 2021	BUY	$34.27 - $40.01 $43,899 - $51,252	1,281 Added 5.93%	22,892 $817,000
Q4 2020 Jan 22, 2021	SELL	$34.07 - $39.94 $5.08 Million - $5.95 Million	-149,029 Reduced 87.34%	21,611 $795,000
Q3 2020 Oct 19, 2020	BUY	$38.11 - $42.99 $2.6 Million - $2.94 Million	68,342 Added 66.81%	170,640 $6.42 Million
Q2 2020 Jul 20, 2020	BUY	$37.87 - $43.58 $1.74 Million - $2 Million	45,823 Added 81.14%	102,298 $4.17 Million
Q1 2020 Apr 24, 2020	BUY	$32.47 - $48.83 $10,195 - $15,332	314 Added 0.56%	56,475 $2.14 Million
Q1 2020 Apr 17, 2020	BUY	$32.47 - $48.83 $1.82 Million - $2.74 Million	56,161 New	56,161 $21.3 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Nepsis Inc., based on Form 13F filings with the SEC.

Stay updated on Nepsis Inc. with notifications on news.